return
to Bauer Lab Homepage
|
C.V.
– Margaret E. Bauer, Ph.D. |
|||
|
|
|
|
|
|
EDUCATION |
|
|
|
|
Institution |
Degree |
Year |
Field of Study |
|
Washington
University, St. Louis, MO |
A.B. |
1985 |
Biological
Sciences |
|
University
of Missouri-Columbia, Columbia,
MO |
M.A. |
1988 |
Molecular
Biology |
|
University
of Wisconsin-Madison, Madison,
WI |
Ph.D. |
1996 |
Medical
Microbiology |
|
Indiana
University School of Medicine, Indianapolis, IN |
Postdoctoral |
2000 |
Infectious
Diseases |
|
|
|
|
|
|
PROFESSIONAL EXPERIENCE |
|
|
|
|
Department & Institution |
Title |
Years |
Field of Study |
|
Department
of Medicine, Indiana
University School of Medicine |
Assistant Scientist |
2000-2004 |
Microbial
Pathogenesis |
|
Department
of Microbiology and Immunology, Indiana
University School of Medicine |
Assistant Professor |
2005-present |
Microbial
Pathogenesis |
|
|
Publications |
|
|
|
|
1. |
Bauer, M. and G. P. Smith. 1988. Filamentous phage morphogenetic signal sequence and
orientation of DNA in the virion and gene-V protein complex. Virology 167: 166-175 |
|
2. |
HŠse, C. C., M.
E. Bauer, and R. A.
Finkelstein. 1994. Genetic characterization of
mannose-sensitive hemagglutinin (MSHA)-negative mutants of Vibrio cholerae derived by Tn5 mutagenesis. Gene 150: 17-25. |
|
3. |
Welch, R. A., M. E. Bauer, A. D. Kent, J. A. Leeds, M. Moayeri,
L. B. Regassa, and D. L. Swenson.
1995. Battling against
host phagocytes: the wherefore of the RTX family of toxins? Infectious Agents and Disease 4:
254-272. |
|
4. |
Bauer, M.
E. and R. A.
Welch. 1996. Characterization of an RTX toxin from
enterohemorrhagic Escherichia coli O157:H7.
Infect. Immun. 64: 167-175. |
|
5. |
Bauer, M.
E. and R. A.
Welch. 1996. Association of RTX toxins with
erythrocytes. Infect.
Immun. 64: 4665-4672. |
|
6. |
Bauer, M.
E. and R. A.
Welch. 1997. Pleiotropic effects of a mutation in rfaC on Escherichia coli hemolysin. Infect. Immun. 65: 2218-2224. |
|
7. |
Hiltke, T. J., M. E. Bauer, J. Klesney-Tait, E. J. Hansen, R. S.
Munson, Jr., and S. M. Spinola.
1999. Effect of normal
and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants. Microb. Pathog. 26: 93-102. |
|
8. |
Bauer, M.
E. and S. M.
Spinola. 1999. Binding of Haemophilus ducreyi to extracellular matrix proteins. Infect. Immun. 67: 2649-2652. |
|
9. |
Al-Tawfiq, J.
A., M. E. Bauer, K.
R. Fortney, B. P. Katz, A. F. Hood, M. Ketterer, M. A. Apicella, and S. M.
Spinola. 2000. A pilus-deficient mutant of Haemophilus
ducreyi is virulent in
the human model of experimental infection. J. Infect. Dis. 181: 1176-1179. |
|
10. |
Bauer, M.
E. and S. M.
Spinola. 2000. Localization of Haemophilus
ducreyi at the
pustular stage of disease in the human model of infection. Infect. Immun. 68: 2309-2314. |
|
11. |
Fortney, K.
R., R. S. Young, M. E. Bauer,
B. P. Katz, A. F. Hood, R. S. Munson, Jr., and S. M. Spinola. 2000. Expression of peptidoglycan-associated lipoprotein
is required for virulence in the human model of Haemophilus ducreyi infection. Infect. Immun. 68: 6441-6448. |
|
12. |
Bauer, M. E., M. P. Goheen, C. A. Townsend, and S.
M. Spinola. 2001. Haemophilus ducreyi associates with phagocytes, collagen,
and fibrin and remains extracellular throughout infection of human
volunteers. Infect. Immun.
69:2549-2557. |
|
13. |
Spinola, S.
M., M. E. Bauer,
and R. S. Munson, Jr. 2002. Immunopathogenesis of Haemophilus
ducreyi infection
(chancroid). Infect. Immun. 70:1667-1676. |
|
14. |
Bong,
C. T. H., M. E. Bauer, and S. M. Spinola.
2002. Haemophilus
ducreyi:
clinical features, epidemiology and prospects for disease control. Microbes and Infection 4:1141-1148. |
|
15. |
Spinola,
S. M., C. T. H. Bong, A. Faber, K. R. Fortney, S. Bennett, C. Townsend, B.
Zwickl, S. D. Billings, T. L. Humphreys, M. E. Bauer, and B. P. Katz. 2003. Host effect on outcome in the human challenge model of Haemophilus
ducreyi
infection. Infect. Immun.
71:6658-6663. |
|
16. |
Bauer,
M. E., C.
A. Townsend, A. R. Ronald, and S. M. Spinola. 2006.
Localization of Haemophilus ducreyi in naturally acquired
chancroid ulcers. Microb. Infect. 8:2465-2468. |
|
17. |
Mount,
K. L. B., C. A. Townsend, and M. E. Bauer. 2007. Haemophilus
ducreyi is
resistant to human antimicrobial peptides. Antimicrob. Agents Chemother. 51:3391-3393. |
|
18. |
Bauer,
M. E., K.
R. Fortney, A. Harrison, D. M. Janowicz, R. S. Munson, Jr., and S. M.
Spinola. 2007. Identification of Haemophilus
ducreyi
genes expressed during human infection.
Microbiol. 154:1152-1160.
|
|
19. |
Bauer,
M. E. C.
A. Townsend, K. R. Fortney, R. Doster, B. P. Katz, S. M. Spinola, and D. M.
Janowicz. 2008. A fibrinogen-binding lipoprotein
contributes to virulence of Haemophilus ducreyi in humans. J. Infect. Dis. 199:684-692. |
|
20. |
Janowicz,
D. M., W. Li, and M. E. Bauer. 2010. Host-pathogen Interplay of Haemophilus
ducreyi. Curr. Op. Infect. Dis. 23:64-69. |
|
21. |
Mount,
K. L. B., C. A. Townsend, S. D. Rinker, X. Gu, K. R. Fortney, B. W. Zwickl,
D. M. Janowicz, S. M. Spinola, B. P. Katz, and M. E. Bauer. 2010. Haemophilus
ducreyi
SapA contributes to cathelicidin resistance and virulence in humans. Infect. Immun. 78:1176-1184. |